Lupus and other autoimmune diseases strike far more women than men. Now there's a clue why
Women are far more likely than men to get autoimmune diseases, illnesses like lupus or rheumatoid arthritis that occur when the immune system mistakenly attacks their own bodies (Source: ABC News: Health)
Source: ABC News: Health - February 1, 2024 Category: Consumer Health News Tags: Health Source Type: news
Yes, Lupus Patients Can Stop MMF Treatment
(MedPage Today) -- Among patients with systemic lupus erythematosus (SLE) managed successfully with mycophenolate mofetil (MMF), rates of disease flare were not massively greater when the drug was withdrawn over several months versus kept at their... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 31, 2024 Category: Rheumatology Source Type: news
Viral protein fragments may unlock mystery behind serious COVID-19 outcomes
Key takeawaysThere remains no clear explanation for why COVID-19, caused by SARS-CoV-2, can result in severe outcomes or death while other coronaviruses just cause common colds, or why COVID-19 symptoms persist after the coronavirus that causes it has been eliminated.A UCLA-led research team has shown that fragments of the coronavirus may drive inflammation by mimicking the action of specific immune molecules in the body.The findings could contribute to not only the understanding and treatment of COVID-19 but also efforts to detect coronaviruses with the potential to cause pandemics before they become widespread.There are ...
Source: UCLA Newsroom: Health Sciences - January 31, 2024 Category: Universities & Medical Training Source Type: news
What to Know About Complementary Treatments for Lupus
Being diagnosed with a chronic illness can be a distressing and disorienting experience. Surveys of people who have chronic diseases have found that many experience a sense of powerlessness, and that they tend to view their condition as more than a threat to their health; it’s also seen as a threat to their psychological well-being, as well as their social and personal identities.
All of these experiences may be heightened among people with lupus, a complex autoimmune condition that tends to arise unexpectedly and in relatively young patients. The unpredictable and highly variable course of the disease can contrib...
Source: TIME: Health - January 17, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance healthscienceclimate Source Type: news
Telitacicept Prompts Positive Responses in Lupus Treatment Telitacicept Prompts Positive Responses in Lupus Treatment
Phase 2b study data also showed a dose reduction in glucocorticoids among those who received the investigational drug compared with patients who received placebo.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 12, 2024 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Source Type: news
SGLT2 Inhibitors Begin to Show Potential in Rheumatology SGLT2 Inhibitors Begin to Show Potential in Rheumatology
Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Rheumatology Source Type: news
A gift of life and love: Thunder Bay artist with lupus prepares for transplant of partner's kidney
After a year on dialysis, Anishinaabe artist Lucille Atlookan is receiving a unique gift from her partner: a kidney. As the Thunder Bay, Ont., couple prepares for transplant surgery in Toronto, we take a deeper look at the challenges faced by people with chronic conditions who travel long distances for treatment. (Source: CBC | Health)
Source: CBC | Health - January 8, 2024 Category: Consumer Health News Tags: News/Canada/Thunder Bay Source Type: news
The Most Exciting New Advancements in Managing and Treating Lupus
The case study involved just one patient: a 20-year-old woman with severe systemic lupus erythematosus (SLE). But the study’s results were so dramatic that they appeared in 2021 in the New England Journal of Medicine.
The woman received a type of cell therapy called CAR-T, which in the past has been used primarily to treat cancer. CAR-T cell therapy involves altering a patient’s immune cells so that they identify and attack problems or pathogens. In people with cancer, that attack is aimed at the diseased cells. But in the NEJM case study, the therapy was directed at the woman’s own B cells,...
Source: TIME: Health - December 27, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news
CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study
SAN DIEGO — When the first lupus patient received CAR-T therapy, researchers watched in amazement as her autoimmune disease rapidly went into remission. Then, they monitored her disease anxiously for months, wondering if it would return — especially as her immune B cells began recovering. Now, two…#sandiego #pjutz #stanforduniversity (Source: Reuters: Health)
Source: Reuters: Health - December 10, 2023 Category: Consumer Health News Source Type: news
How to Accelerate Lupus Solutions with RWD, Upcoming Webinar Hosted by Xtalks
In this free webinar, explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency. Attendees will gain insights into key patient-relevant features that should be covered by real-world data... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 4, 2023 Category: Pharmaceuticals Tags: FVT TDS Source Type: news
Lupus Drug Fails to Reduce Symptoms in Mid-stage Study Lupus Drug Fails to Reduce Symptoms in Mid-stage Study
Roivant Sciences said on Monday its experimental drug to treat systemic lupus erythematosus failed to reduce symptoms of the autoimmune disease in a mid-stage study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
How Viral Infections Cause Long-Term Health Problems
In a few patients, the immune system becomes misdirected, attacking the body instead of the virus. (Source: NYT Health)
Source: NYT Health - November 22, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Multiple Sclerosis Autoimmune Diseases Immune System Long Covid Chronic Fatigue Syndrome Antibodies Mononucleosis Rheumatoid Arthritis Bacteria Lupus Erythematosus Source Type: news
Risks Quantified in Medically Optimized Pregnancy With Lupus Risks Quantified in Medically Optimized Pregnancy With Lupus
Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 22, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Obinutuzumab Preserves Kidney Function in Lupus Nephritis
THURSDAY, Nov. 16, 2023 -- For patients with lupus nephritis (LN), obinutuzumab treatment results in better preservation of kidney function and prevention of LN flares, according to a study published online Nov. 10 in Arthritis&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2023 Category: Pharmaceuticals Source Type: news
Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnancy in Rheumatic Disease Quadruples CVE Risk
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than did pregnant individuals without these conditions.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 13, 2023 Category: Cardiology Tags: Rheumatology News Source Type: news
